Alfredo Castañeda

Dr. Alfredo Castañeda


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
ACAlfredo Castañeda
Alfredo Castañeda
IMIsabel Martin-Blecua
Isabel Martin-Blecua
ECEsmeralda Cebrián-Sastre
Esmeralda Cebrián-Sastre
ACA. Chiner-Oms
A. Chiner-Oms
MTM. Torres-Puente
M. Torres-Puente
Jesus BlazquezJesus Blazquez
Jesus Blazquez
The postreplicative mismatch repair (MMR) is an almost ubiquitous DNA repair essential for maintaining genome stability. It has been suggested that Mycobacteria have an alternative MMR in which NucS, an endonuclease with no structural homology to the canonical MMR proteins (MutS/MutL), is the key factor. Here, we analyze the spontaneous mutations accumulated in a neutral manner over thousands of generations by Mycobacterium smegmatis and its MMR-deficient derivative (ΔnucS). The base pair substitution rates per genome per generation are 0.004 and 0.165 for wild type and ΔnucS, respectively. By comparing the activity of different bacterial MMR pathways, we demonstrate that both MutS/L- and NucS-based systems display similar specificity and mutagenesis bias, revealing a functional evolutionary convergence. However, NucS is not able to repair indels in vivo. Our results provide an unparalleled view of how this mycobacterial system works in vivo to maintain genome stability and how it may affect Mycobacterium evolution.

25 May 2011 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
ACAlfredo Castañeda
Alfredo Castañeda
TDThi Thuy Do
Thi Thuy Do
Jesus BlazquezJesus Blazquez
Jesus Blazquez
Rifampicin is an important first-line antibiotic for the treatment of mycobacterial infections. Although most rifampicin-resistant strains arise through mutations in the rpoB gene in bacteria, a proportion of such strains show no rpoB mutations. This suggests that alternative mechanisms are responsible for rifampicin resistance. We have constructed and analysed a library of 11 000 Mycobacterium smegmatis insertion mutants to find other possible rifampicin-resistance determinants. We found that disruption of trkA, a putative regulator of K+ uptake, leads to increased rifampicin resistance. Our data indicate that TrkA-mediated K+ uptake is essential for maintenance of the M. smegmatis growth rate, its pH homeostasis and membrane potential. In addition to increased rifampicin resistance, inactivation of trkA confers resistance to other hydrophobic agents, such as novobiocin, as well as increased susceptibility to isoniazid and positively charged aminoglycosides. Our results suggest that trkA is a general regulator of antibiotic susceptibility, and the changes in the multidrug susceptibility/resistance pattern detected in the trkA mutant are associated with membrane hyperpolarization. This study sheds light on the role of ion transport activity in intrinsic and acquired antibiotic resistance in mycobacteria.

25 May 2021 in Cells
Verified
Journal Article
Open access
PDF file
ECEsmeralda Cebrián-Sastre
Esmeralda Cebrián-Sastre
IMIsabel Martin-Blecua
Isabel Martin-Blecua
SGSonia Gullón
Sonia Gullón
Jesus BlazquezJesus Blazquez
Jesus Blazquez
ACAlfredo Castañeda
Alfredo Castañeda
The DNA repair endonuclease EndoMS/NucS is highly conserved in Archaea and Actinobacteria. This enzyme is able to recognize and cleave dsDNA carrying a mismatched base pair, and its activity is enhanced by the interaction with the sliding clamp of the replisome. Today, EndoMS/NucS has been established as the key protein of a non-canonical mismatch repair (MMR) pathway, acting specifically in the repair of transitions and being essential for maintaining genome stability. Despite having some particularities, such as its lower activity on transversions and the inability to correct indels, EndoMS/NucS meets the main hallmarks of a MMR. Its absence leads to a hypermutator phenotype, a transition-biased mutational spectrum and an increase in homeologous recombination. Interestingly, polymorphic EndoMS/NucS variants with a possible effect in mutation rate have been detected in clinical isolates of the relevant actinobacterial pathogen Mycobacterium tuberculosis. Considering that MMR defects are often associated with the emergence of resistant bacteria, the existence of EndoMS/NucS-defective mutators could have an important role in the acquisition of antibiotic resistance in M. tuberculosis. Therefore, a further understanding of the EndoMS/NucS-mediated non-canonical MMR pathway may reveal new strategies to predict and fight drug resistance. This review is focused on the recent progress in NucS, with special emphasis on its effect on genome stability and evolvability in Actinobacteria.

21 December 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
RCRosilene Fressatti Cardoso
Rosilene Fressatti Cardoso
IMIsabel Martín-Blecua
Isabel Martín-Blecua
VBVanessa Pietrowski Baldin
Vanessa Pietrowski Baldin
JMJean Eduardo Meneguello
Jean Eduardo Meneguello
JVJosé Ramón Valverde
José Ramón Valverde
ACAlfredo Castañeda
Alfredo Castañeda
Chronic infections caused by M. abscessus are an emerging challenge in public health, posing a substantial health and economic burden, especially in patients with cystic fibrosis. Treatment of M. abscessus infections with antibiotics is particularly challenging, as its complex drug resistance mechanisms, including constitutive resistance through DNA mutation, lead to high rates of treatment failure.

12 April 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
TDThi Thuy Do
Thi Thuy Do
JRJerónimo Rodríguez-Beltrán
Jerónimo Rodríguez-Beltrán
ECEsmeralda Cebrián-Sastre
Esmeralda Cebrián-Sastre
ARAlexandro Rodriguez Rojas
Alexandro Rodriguez Rojas
ACAlfredo Castañeda
Alfredo Castañeda
Jesus BlazquezJesus Blazquez
Jesus Blazquez
Rifampicin is a critical first-line antibiotic for treating mycobacterial infections such as tuberculosis, one of the most serious infectious diseases worldwide. Rifampicin resistance in mycobacteria is mainly caused by mutations in the rpoB gene; however, some rifampicin-resistant strains showed no rpoB mutations. Therefore, alternative mechanisms must explain this resistance in mycobacteria. In this work, a library of 11,000 Mycobacterium smegmatis mc2 155 insertion mutants was explored to search and characterize new rifampicin-resistance determinants. A transposon insertion in the MSMEG_1945 gene modified the growth rate, pH homeostasis and membrane potential in M. smegmatis, producing rifampicin resistance and collateral susceptibility to other antitubercular drugs such as isoniazid, ethionamide and aminoglycosides. Our data suggest that the M. smegmatis MSMEG_1945 protein is an ion channel, dubbed MchK, essential for maintaining the cellular ionic balance and membrane potential, modulating susceptibility to antimycobacterial agents. The functions of this new gene point once again to potassium homeostasis impairment as a proxy to resistance to rifampicin. This study increases the known repertoire of mycobacterial ion channels involved in drug susceptibility/resistance to antimycobacterial drugs and suggests novel intervention opportunities, highlighting ion channels as druggable pathways.

1 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ECEsmeralda Cebrián-Sastre
Esmeralda Cebrián-Sastre
ACA. Chiner-Oms
A. Chiner-Oms
RTRafael Torres-Perez
Rafael Torres-Perez
ICI. Comas
I. Comas
JOJuan C. Oliveros
Juan C. Oliveros
ACAlfredo Castañeda
Alfredo Castañeda
Resistance to the frontline antibiotic rifampicin constitutes a challenge to the treatment and control of tuberculosis. Here, we analyzed the mutational landscape of Mycobacterium smegmatis during long-term evolution with increasing concentrations of rifampicin, using a mutation accumulation assay combined with whole genome sequencing. Antibiotic treatment enhanced the acquisition of mutations, doubling the genome-wide mutation rate of the wild type cells. While antibiotic exposure led to extinction of almost all wild type lines, the hypermutable phenotype of the Δ nucS strain (noncanonical mismatch repair deficient) provided an efficient response to the antibiotic, leading to high rates of survival. This adaptative advantage resulted in the emergence of higher levels of rifampicin resistance, an accelerated acquisition of drug resistance mutations in rpoB (β RNA polymerase) and a wider diversity of evolutionary pathways that led to drug resistance. Lastly, this approach revealed a subset of adaptive genes under positive selection with rifampicin that were able to drive novel rifampicin resistance mechanisms.